EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Overcoming cancer therapy resistance: From drug innovation to therapeutics

Jin-Rui Wei, Meng-Yi Lu, Tian-Hua Wei, Joshua S Fleishman, Hui Yu, Xiao-Li Chen, Xiang-Tu Kong, Shan-Liang Sun, Nian-Guang Li, Ye Yang, Hai-Wen Ni

Drug Resistance Updates · 2025-07 · 81 · 101229

DOI: 10.1016/j.drup.2025.101229 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025-07. Verfasst von Jin-Rui Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210029, China; Th…. Hauptthemen laut MEDLINE: Neoplasms, Drug Resistance, Neoplasm, Antineoplastic Agents. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 290 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Commission of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the major limitations of cancer therapy is the emergence of drug resistance. This review amis to provide a focused analysis of the multifactorial mechanisms underlying therapy resistance,with an emphasis on actionable insights for developing novel therapeutic strategies. It concisely outlines key factors contributing to therapy resistance, including drug delivery barriers, cancer stem cells (CSCs), epithelial-mesenchymal transition (EMT), cancer heterogeneity, tumor microenvironment (TME), genetic mutations, and alterlations in gene expression. Additionally, we explore how tumors evade targeted therapies through pathway-specific mechanisms that restore disrupted signaling pathways. The review critically evaluates innovative strategies designed to sensitize resistant tumor cells, such as targeted protein dedgradation, antibody-drug conjugates, structure-based drug design, allosteric drugs, multitarget drugs, nanomedicine and others We also highlight the importance of understanding the pharmacological actions of these agents and their integration into treatment regimens. By synthesizing current knowledge and identifying gaps in our understanding, this review aims to guide future research and improve patient outcomes in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsDrug Resistance, NeoplasmAntineoplastic AgentsHumansTumor MicroenvironmentEpithelial-Mesenchymal TransitionNeoplastic Stem CellsAnimalsMolecular Targeted TherapyDrug Delivery SystemsSignal Transduction

Stichwörter der Autor:innen

CancerDrug innovationDrug resistanceNanomedicineSmall molecule inhibitorTherapy

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210029, China; The First Clinical College of Nanjing University of Chinese Medicine, Na…
  • Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 210029, China.
  • National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrializa…
  • College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
  • Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210029, China.
  • Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210029, China. Electronic address: fsyy00654@njucm.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Commission of Health

Zitieren

APA

Wei, J. R., Lu, M. Y., Wei, T. H., Fleishman, J. S., Yu, H., Chen, X. L., Kong, X. T., Sun, S. L., Li, N. G., Yang, Y., & Ni, H. W. (2025). Overcoming cancer therapy resistance: From drug innovation to therapeutics. Drug Resistance Updates, 81, 101229. https://doi.org/10.1016/j.drup.2025.101229

Vancouver

Wei JR, Lu MY, Wei TH, Fleishman JS, Yu H, Chen XL, et al. Overcoming cancer therapy resistance: From drug innovation to therapeutics. Drug Resistance Updates. 2025;81:101229. doi:10.1016/j.drup.2025.101229

BibTeX
@article{Wei2025,
  author = {Wei, Jin-Rui and Lu, Meng-Yi and Wei, Tian-Hua and Fleishman, Joshua S and Yu, Hui and Chen, Xiao-Li and Kong, Xiang-Tu and Sun, Shan-Liang and Li, Nian-Guang and Yang, Ye and Ni, Hai-Wen},
  title = {Overcoming cancer therapy resistance: From drug innovation to therapeutics},
  journal = {Drug Resistance Updates},
  year = {2025},
  volume = {81},
  pages = {101229},
  doi = {10.1016/j.drup.2025.101229}
}
Kostenlos starten →